We used a noncompetitive enzyme-linked immunoassay to measure apolipoprotein B (apo-B) concentration in human plasma. Goat anti-lipoprotein B immunoglobulins were adsorbed to the surface of polystyrene balls. After washing, this solid-phase antibody was incubated with antigen (plasma from normal or hyperlipoproteinemic fasting subjects), washed, and then incubated with peroxidase-labeled goat anti-lipoprotein B lgG. After a last washing, we measured the bound label, which provided a direct measurement of the antigen. Under optimized assay conditions, the minimum detectable concentration was 50 ng per assay. The assay may be used to measure apo-B in different lipoprotein fractions (low-or very-low-density) and yields values that compared favorably with those obtained by electroimmunoassay (r = 0.86). The assay offers several advantages over existing techniques: sensitivity, specificity, simplicity, avoidance of radioisotopes, and potential for use with monoclonal antibodies. , and immunonephelometry (8, 9)-have been described, but most have a strict requirement that standard and antigen be of similar size (10). Moreover, some of these techniques cannot be used with monoclonal antibodies, requiring polyclonal antibodies for lattice formation. Enzyme-linked immunoassays (ELlA) have been described as good methods for detecting antigens, primarily because of their sensitivity; usefulness with inexpensive, widely available equipment; utilization of reagents with long shelf lives; and the possibility of using an antiserum that may be univalent with respect to its antigen.
Recent evidence directly correlates the risk of developing premature ischemic heart disease with the concentration of , and immunonephelometry (8, 9)-have been described, but most have a strict requirement that standard and antigen be of similar size (10). Moreover, some of these techniques cannot be used with monoclonal antibodies, requiring polyclonal antibodies for lattice formation. Enzyme-linked immunoassays (ELlA) have been described as good methods for detecting antigens, primarily because of their sensitivity; usefulness with inexpensive, widely available equipment; utilization of reagents with long shelf lives; and the possibility of using an antiserum that may be univalent with respect to its antigen.
Two enzyme imniunoassays for apo-B have been developed (11, 12). In the first, an inhibition ELlA, disposable polystyrene tubes coated with lipoprotein B are used; however, the coated tubes cannot be stored more than a week. The second, a competitive ELlA, requires coating polystyrene tubes with cellulose nitrate and purifying LDL for the preparation of the conjugate. Here we describe a simple, rapid, noncompetitive ELlA for measuring ape-B, in which polystyrene balls are the solid-phase source of antibody. The assay is easier to perform than the previously described ELlA.
Materials and Methods

Materials
Blood samples.
Blood was drawn from normal or hyperlipoproteinemic fasting donors and allowed to clot at room temperature for 60 mm. Serum was separated by low-speed centrifugation at 4#{176}C.
Antigen
and antisera. Lipoprotein B of narrow density range (d = 1.040-1.053kgfL) was purified from pooled plasma of healthy human donors by preparative ultracentrifugation (5) . Its purity was assessed by double-diffusion analysis and electrophoresis on polyacrylamide gel (13). Antiserum to lipoprotein B was prepared in adult female goats or rabbits as described earlier (6).
The specificity of the antisera was assessed by double immunodiffusion (14) and two-dimensional immunoelectrophoresis (15).
From the antiserum obtained, an IgG fraction was prepared by sodium sulfate precipitation followed by ionexchange chromatography (16).
Isolation
of lipoprotein density classes. LDL and VLDL were isolated from serum samples of fasting subjects by sequential preparative ultracentrifugation (17) .
Antibody-enzyme
conjugate.
The antibody-enzyme conjugate was prepared following the procedure described by 
Results
Optimizing assay conditions.
Our experiments showed that anti-lipoprotein by performing duplicate measurements in 20 consecutive assays on different days for samples from the same pool stored at 4#{176}C, was 6.3%.
Analytical recovery. When pure lipoprotein B was added to several sera, which were then assayed, the mean percentage of added lipoprotein accounted for was 103%.
Comparison of method. We have compared results obtained by the proposed method with those given by classic electroimmunoassay (6), generally accepted as a referencequality method, for 50 different samples from patients, selected to include a wide range of apo-B concentrations. Results by the two methods correlated well and the means were closely similar ( Table 1) . technical problems (10) . To determine whether the proposed method measures apo-B accurately in different lipoprotein fractions, we prepared standard curves for apo-B in LDL and VLDL. As Figure 2 shows, these curves were parallel; we conclude that noncompetitive ELLA is well adapted to the quantitation of apo-B in these two lipoprotein density classes. 
Quantification of apo-B in
LDL and VLDL. The accurate quantification of apo-B in LDL and VLDL is hampered by
Discussion
Previous immunoassays for measuring ape-B in plasma and lipoprotein fractions have several disadvantages. In radial immunodiffusion and electroimmunoassay the larger lipoprotein molecules diffuse poorly in agarose gel, so that these methods cannot be automated. Immunonephelometry has a strict requirement about a similar size for the standard and the sample and is not specially suitable for dyslipoproteinemic sera. Radioimmunoassay has been used by several investigators but requires expensive equipment and radioisotope licensing. Enzyme immunoassay provides a specific and highly sensitive method for measuring apo-B.
The precision of noncompetitive ELlA equals that reported for other methods, the greatest source of error being its high sensitivity, which necessitates a high sample dilution. This assay should be applicable to the quantification of other apolipoproteins in human serum or lipoprotein fractions. Recent studies indicate no particular problems for use of monoclonal antibodies with the procedure. Noncompetitive ELlA can be automated by use of microtitre plates (24) and is well suited for screening studies.
